Clinical Trial Update: L9LS MAb in Malian Adults [Phase 2]

View source ↗

Summary

Phase 2 trial results for the L9LS monoclonal antibody in Malian adults with malaria have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Infection

Drugs mentioned

• L9LS MAb (L9LS monoclonal antibody)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Infection, Malaria | Phase 2 | Status: COMPLETED | Results posted: 2025-04-02